Tonix Pharma
TNXP----
Tonix Pharma (TNXP)
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disord...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Tonix Pharma Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$42.20327.13%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 21 at 03:10 PM
Tonix Pharma CMO Gregory Sullivan to retire Aug. 20
- PUBT · Jul 20 at 06:17 AM
Tonix Pharmaceuticals publishes investor deck highlighting TONMYA fibromyalgia launch strategy
- PUBT · Jul 20 at 06:17 AM
Tonix shares TNX-4800 Lyme disease prevention presentation
- PUBT · Jul 16 at 01:17 PM
Tonix Pharmaceuticals investor deck spotlights TONMYA fibromyalgia launch and late-stage pipeline plans
- Unusual Whales · Jul 15 at 08:06 AM
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
- PUBT · Jul 13 at 06:01 AM
Tonix Pharma signs managed Medicare payer deal adding 9 million TONMYA-covered lives effective Jan. 1, 2027
